Language selection

Search

Patent 2570779 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2570779
(54) English Title: A SUPPORT STRUCTURE FOR A MEDICAMENT
(54) French Title: STRUCTURE SUPPORT DESTINE A UN MEDICAMENT
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • B65D 81/26 (2006.01)
  • A61M 15/00 (2006.01)
  • B65D 75/34 (2006.01)
(72) Inventors :
  • LASTOW, OREST (Sweden)
(73) Owners :
  • ASTRAZENECA AB
(71) Applicants :
  • ASTRAZENECA AB (Sweden)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2005-06-21
(87) Open to Public Inspection: 2006-01-05
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/GB2005/002440
(87) International Publication Number: GB2005002440
(85) National Entry: 2006-12-04

(30) Application Priority Data:
Application No. Country/Territory Date
0401654-9 (Sweden) 2004-06-24

Abstracts

English Abstract


A support structure (1) for a medicament comprising a base (2) with at least
one cavity (3) for the medicament and a lid (4) for sealing the medicament
within the cavity (3). Each moisture permeable region of the structure (6) is
protected against the ingress of moisture by locating a moisture absorbing
sink (7) between that region and the ambient air outside the structure (1).


French Abstract

L'invention concerne une structure support (1) destinée à un médicament comprenant une base (2) avec au moins une cavité (3) destinée au médicament et un couvercle (4) destiné à sceller le médicament dans la cavité (3). Chaque zone perméable à l'humidité de la structure (6) est protégée contre l'entrée d'humidité par placement d'un puits absorbant l'humidité (7) entre la zone et l'air ambiant à l'extérieur de la structure (1).

Claims

Note: Claims are shown in the official language in which they were submitted.


8
CLAIMS:
1. A support structure for a medicament comprising a base with at least one
cavity for the medicament and a lid for sealing the medicament within the
cavity, each
moisture permeable region of the structure being protected against the ingress
of
moisture by locating a moisture absorbing sink between that region and the
ambient
air outside the structure, characterised in that each moisture permeable
region
comprises an inner moisture permeable barrier located adjacent to the cavity
and an
outer moisture permeable barrier, the moisture absorbing sink being located
between
the inner and outer barriers thereby reducing the relative humidity (RH) of
the air
passing through it to substantially the relative humidity (RH) of the air
within the
cavity so that there is minimal diffusion of moisture from the sink to the
cavity.
2. A support structure as claimed in Claim 1, wherein the base and the lid are
moisture impermeable and the moisture permeable region of the structure is
located
where the lid is sealed to the base.
3. A support structure as claimed in Claim 2, wherein the moisture absorbing
sink
between the lid and the base is spaced from the periphery of the cavity
thereby
forming an inner moisture permeable region and an outer moisture permeable
region,
the sink breaking the moisture ingress path so that there is minimal diffusion
of
moisture through the inner moisture permeable region to the cavity.
4. A support structure as claimed in any of Claims 1 to 3, wherein the
moisture
absorbing sink comprises a channel in the base surrounding the cavity which
contains dry air.
5. A support structure as claimed in Claim 4, comprising a plurality of
cavities
each having a channel filled with dry air.
6. A support structure as claimed in Claim 5, wherein each channel is
connected
to a single desiccant source which dries the air in all the channels.

9
7. A support structure as claimed in any of Claims 1 to 3, wherein the
moisture
absorbing sink comprises a polymer ring surrounding the cavity and located
between
the lid and the base.
8. A support structure as claimed in Claim 7, comprising a plurality of
cavities
each having a polymer ring.
9. A support structure as claimed in any of Claims 2 to 8, wherein both the
base
and the lid have an aluminium layer for moisture impermeability, the lid being
heat
sealed to the base.
10. A support structure as claimed in Claim 1, wherein the lid is moisture
impermeable and the base material is moisture permeable, the moisture
permeable
regions being located where the lid is sealed to the base and within the base
material
of the cavity walls.
11. A support structure as claimed in Claim 10, wherein a first moisture
absorbing
sink is located between the lid and the base and is spaced from the periphery
of the
cavity and a second moisture absorbing sink is located within the base
material of the
cavity walls thereby forming inner moisture permeable barriers and outer
moisture
permeable barriers, the sink breaking the moisture ingress path so that there
is
minimal diffusion of moisture through the inner moisture permeable barriers to
the
cavity.
12. A support structure as claimed in Claim 10 or Claim 11, wherein the
moisture
absorbing sink comprises a channel containing dry air surrounding the cavity
opening
where the lid is sealed to the base and passing through the cavity walls.
13. A support structure as claimed in Claim 12, comprising a plurality of
cavities
each having a channel containing dry air.

14. A support structure as claimed in Claim 13, wherein each channel is
connected to a single desiccant source which dries the air in all the
channels.
15. A support structure as claimed in any of Claims 10 to 14, wherein the base
is
injection moulded and the lid has an aluminium layer for moisture
impermeability, the
lid being heat sealed to the base.
16 A support structure as claimed in Claim 10, wherein the base comprises
cooperating stackable elements, each element having a plurality of cavities,
the
cavities within one of the elements sitting between the cavities within
another element
when stacked, a moisture absorbing sink being formed by the spacing between
the
cooperating elements.
17. A support structure for a medicament substantially as herein described
with
reference to the accompanying drawings.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
1
A SUPPORT STRUCTURE FOR A MEDICAMENT
The present invention relates to a support structure for a medicament in the
form of, for example, a blister pack for a drug or an injection moulded drug
dosing
element as used in an inhalation device. A typical blister pack for a
medicament is
described in WO 01/45777 and a typical drug dosing element is described in US
5,590,645.
With powdered medicaments there is a demand for a package/support
structure which is able to keep the powder free from the ingress of moisture
both
during storage and when the powdered medicament has been loaded into a
delivery
io device. Similarly, if the drug is in tablet or capsule form there is also a
demand to
keep the tablets/capsules, which are typically held in a blister pack, free
from the
ingress of moisture. The main weakness in a support structure which has a lid
sealed to a base, having one or more cavities for holding the medicament, is
in the
region where the lid is sealed to the base. If the support structure is in the
form of a
1s blister pack, the lid and base are often both made from a material having
an
aluminium layer which makes these elements moisture impermeable. Accordingly,
the only region where moisture can penetrate the blister pack is through the
lid
sealing region which is typically a heat seal. If the base of the blister pack
is made
from a plastic material then there will also be moisture ingress through the
base
20 material to the medicament. If the support structure is in the form of an
injection
moulded dosing element, the injection moulded base will be made from a
moisture
permeable material whereas the lid will typically have an aluminium layer
making it
moisture impermeable. In this case, there will also be moisture ingress
through both
the heat seal between the lid and base and through the base material.
25 The problem of moisture ingress has been overcome to a certain degree in
prior art inhalation device components by using aluminium containing foil
materials
for both the lid and base and spacing adjacent cavities by approximately 3mm.
With
such a construction, moisture within an empty cavity does not then compromise
an
adjacent cavity which still contains a dose of medicament. The only weakness
so resides in the heat seal between lid and base. A disadvantage with this
construction
is that there is a limit to the number of doses which can be arranged on the
blister
pack/dosing element due to the spacing requirement.

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
2
Other prior art solutions include providing a desiccant source which is
connected to or placed within a cavity containing the medicament. However,
this
solution is reactive only, in that moisture is removed after having penetrated
a cavity
rather than preventing moisture from entering the cavity in the first place.
Similarly,
an alternative solution has been to use a desiccant box inside an aluminium
bag
which holds a plurality of medicament doses, e.g., tablets, but this form of
moisture
protection is destroyed when the bag is opened for the first time so that
there is no in-
use stability. For further examples of prior art solutions, reference should
be made to
WO 03/61742 and US 6,132,394.
In view of the problems discussed above, the present invention seeks to
provide moisture protection for the medicament and to maximise the number of
doses arranged on the support structure.
According to the present invention, there is provided a support structure for
a
medicament comprising a base with at least one cavity for the medicament and a
lid
is for sealing the medicament within the cavity characterised in that each
moisture
permeable region of the structure is protected against the ingress of moisture
by
locating a moisture absorbing sink between that region and the ambient air
outside
.the structure.
Preferably, the sink reduces the relative humidity (RH) of the air passing
through it to substantially the relative humidity (RH) of the air within the
cavity so that
there is minimal diffusion of moisture from the sink to the cavity.
Preferably, each moisture permeable region comprises an inner moisture
permeable barrier located adjacent to the cavity and an outer moisture
permeable
barrier, the moisture absorbing sink being located between the inner and outer
barriers.
Preferably, the base and the lid are moisture impermeable and the moisture
permeable region of the structure is located where the lid is sealed to the
base.
Preferably, the moisture absorbing sink between the lid and the base is
spaced from the periphery of the cavity thereby forming an inner moisture
permeable
3o region and an outer moisture permeable region, the sink breaking the
moisture
ingress path so that there is minimal diffusion of moisture through the inner
moisture
permeable region to the cavity.

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
3
Preferably, the moisture absorbing sink comprises a channel in the base
surrounding the cavity which contains dry air.
Preferably, there is provided a plurality of cavities each having a channel
filled
with dry air.
s Preferably, each channel is connected to a single desiccant source which
dries the air in all the channels.
Preferably, the moisture absorbing sink comprises a polymer ring surrounding
the cavity and located between the lid and the base.
Preferably, there is further provided a plurality of cavities each having a
io polymer ring.
Preferably, the base and the lid have an aluminium layer for moisture
impermeability, the lid being heat sealed to the base.
Preferably, the lid is moisture impermeable and the base material is moisture
permeable, the moisture permeable regions being located where the lid is
sealed to
15 the base and within the base material of the cavity walls.
Preferably, a first moisture absorbing sink is located between the lid and the
base and is spaced from the periphery of the cavity and a second moisture
absorbing
sink is located within the base material of the cavity walls thereby forming
inner
moisture permeable barriers and outer moisture permeable barriers, the sink
2o breaking the moisture ingress path so that there is minimal diffusion of
moisture
through the inner moisture permeable barriers to the cavity.
Preferably, the moisture absorbing sink comprises a channel containing dry air
surrounding the cavity opening where the lid is sealed to the base and passing
through the cavity walls.
25 Preferably, there is further provided a plurality of cavities each having a
channel containing dry air.
Preferably, each channel is connected to a single desiccant source which
dries the air in all the channels.
Preferably, the base is injection moulded and the lid has an aluminium layer
30 for moisture impermeability, the lid being heat sealed to the base.
Preferably, the base comprises cooperating stackable elements, each element
having a plurality of cavities, the cavities within one of the elements
sifting between

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
4
the cavities within another element when stacked, a moisture absorbing sink
being
formed by the spacing between the cooperating elements.
Preferred embodiments of the present invention will now be described in
detail, by way of example only, with reference to the accompanying drawings,
of
s which:
Figure 1 is a graphic representation of the relative humidity gradient across
a
barrier for a drug with conventional moisture protection;
Figure 2 is a graphic representation of the relative humidity gradient across
a
barrier arrangement with moisture protection according to the present
invention;
Figure 3 is a section through one blister in a blister pack with moisture
protection according to a preferred embodiment of the present invention;
Figures 4A, 4B and 4C depict preferred embodiments of blister packs with
multiple cavities having moisture protection;
Figure 5 is a plan view of a section of a dosing element for an inhalation
1s device having moisture protection according to a preferred embodiment of
the
present invention;
Figure 6 is a sectional view in direction X-X through the dosing element in
Figure 5;
Figure 7 depicts a further preferred embodiment of a dosing element having
moisture protection;
Figure 8 depicts the underside of annular ring 111 b in Figure 7; and,
Figure 9 is an enlarged view of part of the annular ring in Figure 8.
Reference should now be made to Figure 1 which depicts the relative humidity
(RH) gradient across a barrier which is moisture permeable. The barrier could
be, for
example, the material from which the base of the support structure is made or
the
heat seal between the lid and base of the support structure. The moisture
ingress
through the barrier arises because the relative humidity in the ambient air
outside the
support structure is typically 70% whereas the relative humidity of the air
and
powdered drug within a cavity is typically 20%. The moisture ingress arises
both
from the ambient air and from neighbouring cavities which have already been
emptied. The powdered drug is protected only by a single barrier and moisture
is
continually transported through the barrier by gradient driven diffusion. The
transport

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
of moisture continues until the relative humidity inside a cavity reaches the
ambient
level. Moisture protection can only be improved by increasing the barrier
thickness or
modifying the properties of the barrier material.
In the present invention, it is proposed to locate a moisture absorbing sink
5 between each moisture permeable region of the support structure and the
ambient
air. This can be achieved, for example, by breaking the single barrier into an
outer
barrier and an inner barrier with the sink located between the two barriers.
Figure 2
depicts a preferred arrangement where the sink effectively breaks the moisture
ingress path. The relative humidity gradient across the outer barrier is high
giving
lo moisture diffusion as in Figure 1. However, when the moisture passes into
the sink
which has high moisture absorption qualities, any moisture diffusion through
the inner
barrier will be low. For example, if dry air is present in the sink, the
relative humidity
of the air in the sink could fall to 20% (which is a similar level to that
within the cavity)
with the result that the relative humidity gradient would be very low across
the inner
barrier and the moisture ingress path could be broken.
Figure 3 depicts a first preferred embodiment of the present invention where
the support structure is in the form of a blister pack 1 having a base 2 with
at least
one cavity 3 holding a medicament and a lid 4 which is sealed to the base 2 by
way
of heat seals 5 and 6. Between the outer seal 5 and the inner seal 6 is a
moisture
2o absorbing sink in the form of a channel 7 which surrounds the cavity 3. The
channel
7 could contain dry air to remove moisture in the region of the lid 4. The
moisture
ingress path M for this support structure will only be through the heat seals
5 and 6
as the blister pack base 2 and lid 4 would typically be manufactured from a
moisture
impermeable material having an aluminium component. The moisture ingress path
M
would result in a relative humidity gradient similar to that depicted in
Figure 2. The
outer barrier would be heat seal 5 and the inner barrier would be heat seal 6.
The
dry air in channel 7 would be dried by way of a desiccant. If the dry air
reduces the
relative humidity in the channel 7 to approximate(y 20% then there will only
be
minimal moisture diffusion through the heat seal 6 to the cavity 3 assuming
that the
so relative humidity within cavity 3 is also approximately 20%.
Reference should now be made to Figures 4A, 4B and 4C which depict three
configurations for a blister pack having a plurality of cavities 3. In Figure
4A each

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
6
cavity 3 is surrounded by a dry air channel 7. The channels 7 are all
connected to a
desiccant 8 which ensures that air within the channels is continually dried to
the
required level. The channels and desiccant reservoir would typically be cold
formed
in the same manufacturing process step as the cavities. Figure 4B depicts a
further
s modification using a rectangular channel configuration. Figure 4C depicts a
preferred
configuration when the moisture absorbing sink for each cavity 3 is a moisture
absorbing material, e.g., a polymer in the form of a nylon ring 9. In this
case, there is
no need for a desiccant and each cavity 3 has a dedicated nylon ring which
sits
between the base 2 and lid 4 of the support structure.
In Figure 5, the support structure for the medicament is in the form of an
annular drug dosing element 101. This type of dosing element typically sits
within an
inhalation device which is able to index the drug cavities 103a, 103b and 103c
past a
mechanism which ruptures the lid 104 and allows the user to draw the drug from
each cavity. Figure 5 shows a segment of the annular dosing element 101
1s containing three adjacent cavities 103a, 103b, 103c. One of the cavities
103a is
empty whereas the other two cavities 103b and 103c still contain the powdered
drug.
Figure 6 is a sectional view taken in direction X-X through the dosing element
in
Figure 5.
The base 102 of the dosing element 101 would typically be injection moulded
2o and hence would be moisture permeable. With this arrangement, moisture
protection
is needed both where the lid 104 is heat sealed to the base 102 and within the
base
material. There are channels 107 running between adjacent cavities and beneath
each cavity through the base 102.
The channels 107 all connect to a desiccant 108 which dries the air in the
2s channels to reduce the relative humidity to that within the cavities.
For cavity 103b, the outer heat seal 105 runs around the outer and inner
peripheries of the annular dosing disc. There is also an outer moisture
barrier 109 in
the base 102. The channel 107 creates the inner barriers in the form of the
inner
heat seal 106 and the inner moisture barrier 110 in the base 102.
30 When the cavity 103a has been emptied, the inner heat seal 106 for that
cavity
becomes the outer heat seal 105 for cavity 103b thereby ensuring that the
empty
cavity 103b is not a source for moisture ingress.

CA 02570779 2006-12-04
WO 2006/000758 PCT/GB2005/002440
7
Figure 7 depicts a preferred construction for the dosing elPment 101 which
comprises two cooperating annular rings 111 a and 111 b which sit one above
the
other within a containing tray 112. The spacing between the annular rings 111
a and
111 b forms channels 107.
This arrangement allows each cavity to be spaced from an adjacent cavity by
as little as 1mm. In this way, 60 cavities can be arranged on a dosing disc
101 with a
diameter of 72mm. A desiccant 108 (not shown) to dry the air in the channels
107
between components 111 a, 111 b and 112 sits on the underside of annular ring
111 b
(see Figures 8 and 9) in a groove 113. A lid 104 would be heat sealed to the
io arrangement shown in Figure 7.
The annular ring 111 a has a plurality of cavities 114 and the annular ring
111 b
has a plurality of cavities 115.
With this arrangement, it is not necessary to injection mould the annular
rings
such that there are separate channels as in Figure 5. It is sufficient to
injection mould
1s the drug cavities 114 and 115 in the annular rings and sit the annular
rings one
above the other within the containing tray 112. The groove 113 for the
desiccant is
located on the underside of annular ring 111 b as viewed in Figure 7. The
spacing
between the annular rings 111 a and 111 b is sufficient for humidity
transport. Tooling
is considerably simpler and there is no need to form the narrow channels
depicted in
2o Figure 5. Spacing between the annular rings can be increased, for example,
by
increasing the roughness of the walls or applying a lattice pattem to the
walls.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Application Not Reinstated by Deadline 2011-06-21
Time Limit for Reversal Expired 2011-06-21
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2010-06-21
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2010-06-21
Inactive: Cover page published 2007-02-06
Letter Sent 2007-02-01
Inactive: Notice - National entry - No RFE 2007-02-01
Application Received - PCT 2007-01-18
National Entry Requirements Determined Compliant 2006-12-04
Application Published (Open to Public Inspection) 2006-01-05

Abandonment History

Abandonment Date Reason Reinstatement Date
2010-06-21

Maintenance Fee

The last payment was received on 2009-03-11

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 2006-12-04
Registration of a document 2006-12-04
MF (application, 2nd anniv.) - standard 02 2007-06-21 2007-03-16
MF (application, 3rd anniv.) - standard 03 2008-06-23 2008-03-19
MF (application, 4th anniv.) - standard 04 2009-06-22 2009-03-11
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ASTRAZENECA AB
Past Owners on Record
OREST LASTOW
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2006-12-03 7 368
Drawings 2006-12-03 5 140
Claims 2006-12-03 3 102
Abstract 2006-12-03 1 54
Representative drawing 2006-12-03 1 3
Cover Page 2007-02-05 1 31
Notice of National Entry 2007-01-31 1 205
Courtesy - Certificate of registration (related document(s)) 2007-01-31 1 127
Reminder of maintenance fee due 2007-02-21 1 110
Reminder - Request for Examination 2010-02-22 1 119
Courtesy - Abandonment Letter (Maintenance Fee) 2010-08-15 1 174
Courtesy - Abandonment Letter (Request for Examination) 2010-09-26 1 164
PCT 2006-12-03 4 138